Glenmark Pharmaceuticals Limited announced that Mr. Rajesh Desai has ceased to be an Executive Director of the company due to superannuation with effect from close of working hours on March 31, 2017. Mr. Desai will continue to be on the Board as a Non-Executive Director of the company.